Common TitleASTRAL-5
Official Title Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study
Phase Phase III
ClinicalTrials.gov NCT02480712
Funding
IndustryGilead Sciences
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy(8 trials)
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza(4 trials)
Dolutegravir Tivicay(15 trials)
Dolutegravir-Abacavir-Lamivudine Triumeq(4 trials)
Dolutegravir-Lamivudine Dovato(8 trials)
Dolutegravir-Rilpivirine Juluca(2 trials)
Doravirine Pifeltro(5 trials)
Doravirine-Tenofovir DF-Lamivudine Delstrigo(4 trials)
Efavirenz Sustiva(17 trials)
Efavirenz-Tenofovir DF-Emtricitabine Atripla(10 trials)
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya(5 trials)
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild(5 trials)
Etravirine Intelence(3 trials)
Fostemsavir Rukobia(2 trials)
Ibalizumab Trogarzo(2 trials)
Maraviroc Selzentry(5 trials)
Raltegravir Isentress(10 trials)
Rilpivirine Edurant(5 trials)
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey(2 trials)
Rilpivirine-Tenofovir DF-Emtricitabine Complera(8 trials)
Tenofovir alafenamide-Emtricitabine Descovy(17 trials)
Tenofovir DF-Emtricitabine Truvada and Multiple Generics(25 trials)Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.